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Abstract : The purpose of this study was to examine the effects of intravenous injection of
urotensinII on the systemic blood pressure and heart rate, and to examine whether the
intraperitoneal administration of urotensinII evoked the stimulation of central neurons.
Urotensin, originally isolated fish neuro-endocrine systems, is a peptide which consists of 12
amino acids. Lately human urotensinII was identified to be consisted from 11 amino acids.
Receptors of urotensin have been found to highly distribute in the mammalian cadrdiovascular
systems. It has been reported that urotensin evoked contraction of thoracic artery, while the
dilatation of blood vessels was alternatively induced. In this study, we examined the effects of
peripheral injection of rat urotensinII consisted of 14 amino acids on the circulation and on the
activity of neurons in the brain. It was found that intravenous injection of rat urotensinII
elicited dose-dependently decrease in blood pressure, and increase or decrease in heart rate.
To examine whether an intraperitoneal injection of rat urotensinII induced an excitation of
central neurons, we used immunohistochemical method to study the expression of c-Fos
protein in neurons of the rat brain after intraperitoneal injection of rat urotensinII (test
experiment). In the control experiment rat was intraperitoneally injected saline solution
without rat urotensinII. It was found that intraperitoneal injection of rat urotensinII induced
expression of c-Fos protein in several nuclei in the brain. These results suggested that rat
urotensinII might exhibit physiological functions via central neuronal pathway as well as
peripheral direct pathways.
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INTRODUCTION
A number of physiologically active peptides derived
from internal organs have been discovered in these
recent 20 years1). In our laboratory we have performed
experiments on the hypotheses that these
physiologically active peptides may play their role via
central neurons to the target organs, not only direct
actions to the organs. And we have reported several
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studies of effects of some of these active peptides on
physiological functions. Gastrin, well known to induce
gastric acid secretion, was found to induce
stimulation of neurons in the lateral habenular
nucleus, central nucleus of amygdala, lateral
parabrachial nucleus, solitary tract nucleus and dorsal
motor nucleus of the vagus nerve2). Galanin that is
known to have inhibitory action to gastric acid
secretion was found to stimulate neurons in the area
postrema3). Intravenous (i.v.) administration of leptin,
that is noted to have pathophysiological function in
relationship to obesity, was found to induce
stimulation in neurons in some nuclei in the brain4).
Furthermore, effects of intravenous administration of
ghrelin and apelin on the central neurons were
studied in our laboratory5, 6). In a series of our
experiments, we have suggested that physiologically
active peptides cause stimulatory influence on the
central neurons to exhibit their physiological
functions.
UrotensinII, originally isolated from nervous
systems of fishes, is a cyclic peptide consisted of 12
amino acids7). Recently, in human was identified
human urotensinII consisted of 11 amino acids, and
the receptors of the peptide were found to distribute
densely in the cardiovascular systems of mammals. It
was reported in the experiments using rat arterial
preparation that the urotensinII showed much
stronger vasoconstriction than endothelin8). On the
other hand, human urotensinII was reported to have
vasodilatory actions9). Considering these
contradictory reports, we were urged to examine
what type of cardiovascular responses may be caused
by the peripheral administration of rat urotensinII.
It is well known that proto-oncogene c-fos induces
c-Fos protein transiently within neurons in response
to various kinds of stimulations, and the induction of
c-Fos protein in neurons starts about 20 min after the
stimulation10, 11). So far, no studies have been reported
on the expression of c-Fos protein in central neurons
after peripheral or central injection of urotensinII.
Second, we undertook to survey the neuronal
expression of c-Fos protein throughout the CNS after
intraperitoneal (i.p.) injection of urotensinII.
UrotensinII was administered intraperitoneally, but
not intravenously, to inhibit unexpected expression of
c-Fos protein to a minimum due to stimulation of
central neurons during the operations for the
cannulation of trachea, artery and vein. In the
previous reports from our laboratory, the operational
treatment of animals such as cannulation of artery
and vein induced was found to induce much more c-
Fos protein in the central neurons 5, 6).
In this study, first, cardiopulmonary responses
were investigated, and secondly, distribution of c-Fos-
immunoreactive (c-Fos-ir) neurons after i.p.
administration of rat urotensinII was surveyed
through the rat brain.
MATERIALS AND METHODS
All of the steps of the experimental procedures
were conducted in agreement with the guiding
principles for the care and use of experimental
animals approved by the Society for Neuroscience.
Experiments were done on male Wister rats weighing
250-270 g (9-10-weeks old, SLC, Japan, Shizuoka,
Japan). To avoid any restlessness of a single rat，
some rats were housed in a cage in quiet room under
conditions of regulated illumination (LD12:12, light on
at am 08:00) and constant temperature (22 ± 2℃) with
ad lib water and rat chow (MF, Oriental Yeast Co.,
Ltd., Tokyo, Japan). 
In the first experiments, rats (n=4) were
anesthetized with i.p. injection of  pentobarbital
sodium (Abbott, USA; 50 mg/kg). The trachea was
cannulated with vinyl tubing (2 mm in internal
diameter). Femoral artery and vein were cannulated
with polyethylene catheters (0.58 mm, internal
diameter). Systemic arterial blood pressure (ABP) was
measured with a pressure transducer (TP-400T,
Nihon Kohden, Japan) connected to carrier amplifier
(AP601G, Nihon Kohden, Japan), and heart rate (HR)
was computed from pulse pressure by a
cardiotachometer (AT601G, Nihon Kohden, Japan).
ABP and HR were recorded on a recticorder (RJG4226,
Nihon Kohden, Japan), urotensinII in 0.9% NaCl
solution was administered into the femoral vein to
induce cardiopulmonary responses. Rectal
temperature was maintained at 37℃ with an infrared
heat lamp.
In the second experiments, we undertook to
examine which neurons in the CNS may express c-
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Fos protein after intraperitoneal injection of
urotensinII (300 μg/kg) in 1 ml of 0.9% NaCl solution
using Wistar rat (n=1). One and a half hour after the
urotensinII injection, rat was anesthetized by i.p.
injection of pentobarbital sodium (80 mg/kg, Abbott,
USA), and perfused via the left ventricle with about 20
ml of saline to flush out the blood. This was
immediately followed by 100 ml of 0.5%
glutaraldehyde and 4% paraformaldehyde (PFA,
Merck, German) in 0.1 M phosphate buffer (PB, pH 7.4)
under pressure of 100-120 mmHg, and 400 ml of 4%
PFA in PB under hydrostatic pressure. The brain was
removed and cut into two blocks at the level between
superior and inferior colliculi. They were fixed in 4%
PFA in PB for further 1.5 h at 4℃, then soaked
stepwise in 10, 20, 25% sucrose in PB at 4℃. Each
brain block was frozen and cut into serial transverse
sections at 40 μm in thickness. The sections were
collected in plates containing PB chilled by ice water.
One group of every fourth section was rinsed in 0.1 M
Tris-saline (TS，pH 7.4) three times, incubated with
0.5% bovine serum albumin (BSA) in TS for 20 min and
incubated with sheep anti-c-Fos polyclonal antiserum
(1:100; sc-52, Santa Cruz Biotech. Inc., USA) in 0.5%
BSA at 4℃ for 16 h. The following procedures were
conducted at room temperature. The sections were
rinsed three times in TS, and then incubated in avidin
and biotin solution respectively for 15 min. Thereafter
they were incubated for 20 min with 2% normal rabbit
serum in TS to block nonspecific bindings, and
incubated for 60 min with anti-sheep IgG in TS. After
rinsed three times in TS, the sections were incubated
for 60 min in Vectastatin ABC kit (Vector Lab.,
Burlingame, CA, USA), and then treated with
diaminobenzidine (DAB)/nickel solution containing
0.003% H2O2. After that, the sections were rinsed in
TS twice and rinsed further in PB. They were
mounted on glass slides and dried at room
temperature. The sections on the slides were
dehydrated in a graded ethanol series (50%, 70%, 95%,
99%), infiltrated with xylene and coverslipped in
Permount (Fisher Comp., USA). In the control
experiment, rat (n=1) was sham-operated and injected
with 200 μl of 0.9% NaCl solution. Brain sections
were similarly processed as above. c-Fos protein
localized in neuronal nuclei was visualized as black
precipitates of nickel-intensified DAB reaction
products. The c-Fos-ir neurons were surveyed under
bright-field microscopy. Brain histology was checked
against the rat brain atlas of Swanson12). Statistical
analysis of data of the cardiovascular responses was
performed using student t-test.
RESULTS
Typical examples of cardiopulmonary responses to
the intravenous injection of rat urotensinII were
shown in Fig. 1. The dose of 150 μg/kg of rat
urotensinII showed almost no cardiopulmonary
Fig. 1 Typical example of cardiopulmonary responses to intravenous injection of rat urotensinII (300
μg/kg). Abbreviations: ABP: arterial blood pressure, bpm: beats per minute, HR: heart rate,
mmHg: millimeter mercury, VT: tidal volume.
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responses, but the dose of 300 μg/kg of the peptide
showed clear cardiac responses of decreased ABP,
and increased or decreased HR with the maximum
level at around 2-3 minutes after the injection of rat
urotensinII. The data in four experiments were
summarized in Table I. There was, however, no
statistically significant difference in the ABP between
before and 3 minutes after injection of urotensinII (see
Table I). Respiratory response was slightly observed
as shown in Fig. 1. All these responses recovered to
the original level at around 12 to 15 minutes after the
injection of rat urotensinII. 
Table I：Cardiovascular responses to the intravenous injection of rat urotensinII (300 μg/kg）
Table II：Number of c-Fos-ir neurons in nuclei after intravenous injection of rat urotensinII (300 μg/kg)
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It was found that intraperitoneal injection of
urotensinII induced expression of c-Fos
immunoreactive neurons in several nuclei in the brain.
Table II showed number of c-Fos-ir neurons induced
in four nuclei of the brain in the test experiment (i.p.
injection of urotensinII) and control experiment (i.p.
injection of 0.9% NaCl solution). c-Fos-ir neurons were
found in the ventromedial nucleus of hypothalamus
(VMH), lateral parabrachial nucleus (PBL), the
complex of the solitary tract nucleus (NTS)/dorsal
motor nucleus of the vagus nerve (DMX), and the
ventrolateral medulla (VLM). Numbers of c-Fos-ir
neurons these nuclei in the test experiment were
found to be 2- to 3-times those in the control
experiment.
DISCUSSION
It was found that intravenous injection of rat
urotensinII induced decreases in the ABP, though
there were no statistically significant differences in
the ABP between before and 3 minutes after the i.v.
injection of urotensinII. This present result was in
agreement with the report by Gardiner et al, but
contrary to the report by others who observed strong
contraction of blood vessels by the injections of
urotensinII8). It has been suggested that endogenous
urotensinII and receptors of urotensinII exists in the
rat arterial vessels. The depressor response may be
induced via the receptors, though the mechanism
remains to be clarified. In this experiment it was
found that many c-Fos-ir neurons were expressed in
the VLM. Thus, the depressor response may be
induced via the depressor neurons located in the
caudal ventrolateral medulla13). On the other hand, the
i.v. injection of urotensinII did not induce constant
responses of HR. Thus no definite mechanism might
not be suggested on the response of HR, even though
the increase of HR might be induced at least via the
baroreceptor reflex HR14, 15).  Actually, c-Fos-ir
neurons were found to be expressed in the PBL and
NTS/DMX. The PBL have been known to mutual
connections with neurons in the hypothalamus and
those in the brainstem such as NTS and DMX. The
NTS is known to be the site receiving primary sensory
information from the internal organs, and the neurons
in the DMX to have parasympathetic efferent
projections to heart15, refs in there). Thus, as already
described above, the depressor and tachy- or hypo-
cardiac responses may be induced through neurons in
these nuclei in the medulla oblongata, though further
study is needed to clarify the mechanism of the
responses of HR to the i.v. injection of urotensinII.
c-Fos-ir neurons were also found to be expressed in
the VMH. It was reported that in the noradrenalin
turn-over experiment, electrical stimulation of the
VMH induced acceleration of sympathetic activity to
wide-range peripheral organs. The VMH is also well
known to be the site of satiety center16). Thus, the rat
urotensinII may have some role in the regulation of
sympathetic activity to the internal organs, as well as
the regulation of feeding. Taking other physiological
and behavioral functions into consideration, the
neurons in the VMH may influence the sympathetic
pathways.
In conclusion intravenous injection of rat
urotensinII was found to induce depressor, tachy- or
hypo-cardiac responses and slight respiratory
response. Intraperiotneal injection of rat urotensinII
induced stimulation of neurons in the VMH as well as
neurons in the nuclei of cardiovascular center of the
NTS/DMX and the VLM. The present results suggest
that rat urotensinII might play some roles in the
regulation of feeding as well as the regulation of
cardiovascular function via central neuronal pathway
as well as peripheral direct pathways. 
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